lobbying_activities: 3367364
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3367364 | e1c03b62-b015-4a6b-9bc4-4386e6d4c65f | Q1 | PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) | 400265213 | PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) | 2025 | first_quarter | TOB | Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 1320000 | 0 | 0 | 2025-04-21T20:13:30-04:00 |